GE's Patented Dual BOP LMRP/Lower Stack Interchangeability Offers Rig Operators More Flexibility
HOUSTON---May 2, 2012---With the offshore production industry seeking to increase the efficiency and availability of its deepwater equipment, GE (NYSE: GE) has introduced a new blowout preventer (BOP) stack with an interchangeable lower marine rise package (LMRP) and lower stack frames.
business unit
tags
- New Technology Can Cut and Seal with up to 1.9 Million Pounds of Force
- Patent-Pending Technology Can Centralize and Shear Offset Pipe
- Latest Example of GE Innovation for the Deepwater Sector
HOUSTON---May 2, 2012---GE Oil & Gas (NYSE: GE) is introducing its next-generation technology for shearing and sealing wellbore tubulars at the 2012 Offshore Technology Conference (OTC) in Houston.
business unit
tags
Results, including promising 2012 outlook, to be released at Canadian Restaurant Investment Summit May 30 in Toronto
TORONTO (ON) -- As the economy moves from recovery to expansion, Canadians are expected to cautiously increase their spending at restaurants and the Canadian foodservice industry should grow modestly this year, according to the first annual Canadian Chain Restaurant Industry Review, an extensive research report commissioned by GE Capital and compiled by fsSTRATEGY and NPD Group Canada.
business unit
tags
Eden Prairie, Minn. -- April 30, 2012 -- GE Capital Fleet Services today announced the results of its 17th annual fleet passenger car maintenance study, which found that overall fleet car maintenance costs continued a three-year trend of slight decreases. Maintenance costs continued to decline in 2011 as a result of increased vehicle replacement in 2010, which in-turn decreased the average cost of repairs per vehicle.
business unit
tags
BETHESDA, MD -- April 30, 2012 --- GE Capital, Healthcare Financial Services announced today that it was sole lender and administrative agent on $7.5 million in senior secured credit facilities for PharmAthene, consisting of a $2.5 million term loan and a $5 million revolving line of credit. The financing will be used for general working capital purposes.
Headquartered in Annapolis, MD, PharmAthene is a leading biodefense company that develops and commercializes medical products to counter biological and chemical weapons.